Advances in the pathology of glomerular diseases

Contributions to Nephrology

Volumn 181, Issue , 2013, Pages 12-21

  Weening, Jan J ^a   Ronco, Pierre ^b   Remuzzi, Giuseppe ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SORBONNE UNIVERSITÉ   (France)

^c MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANCA ASSOCIATED VASCULITIS; EPITHELIUM CELL; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; MEMBRANOUS GLOMERULONEPHRITIS; PATHOLOGY; PODOCYTE; REVIEW;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; EPITHELIAL CELLS; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY GLOMERULUS; PODOCYTES;

EID: 84879074240     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000348639     Document Type: Review

References (28)

1. Weening JJ, Jennette JC: Historical milestones in renal pathology. Virchows Archiv 2012; 461:3-11.
2. Berg JG, Weening JJ: Role of the immune system in the pathogenesis of idiopathic ne-phrotic syndrome. Clin Sci 2004; 107:125-136. (Pubitemid 39070928)
3. D'Agati VD, Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis. N Engl J Med 2011; 365:2398-2411.
4. Genovese G, Friedman DJ, Ross MD, Lecor-dier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR: Association of trypano-lytic ApoL1 variants with kidney disease in African-Americans. Science 2010; 329:841-845.
5. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17:952-960.
6. Maas RJ, Wetzels JF, Deegens JK: Serum-soluble urokinase receptor concentration in primary FGS. Kidney Int 2012; 81:1043-1044.
7. Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschênes G, Remuzzi G, Ulinski T, Ronco P: Early-childhood membranous nephropa-thy due to cationic bovine serum albumin. N Engl J Med 2011; 364:2101-2110.
8. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11-21.
9. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF: Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23:1735-1743.
10. Debiec H, Ronco P: PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
11. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cat-tran DC, Salant DJ: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011; 22:1543-1550.
12. Debiec H, Martin L, Jouanneau C, Dautin G, Mesnard L, Rondeau E, Mousson C, Ronco P: Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy. Am J Transplant 2011; 11:2144-2152.
13. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathie-son PW, Kleta R: Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364:616-626.
14. Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A, Marasà M, Remuzzi G: Rituximab in idio-pathic membranous nephropathy. J Am Soc Nephrol 2012; 23:1416-1425.
15. Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A, Bruno F, Radice A, Furci L, Argentiero L, Carnevali ML, Messa P, Scolari F, Sinico RA, Gesualdo L, Fervenza FC, Allegri L, Ravani P, Ghiggeri GM: Coexistence of different circulating anti-podocyte antibodies in membranous ne-phropathy. Clin J Am Soc Nephrol 2012; 7: 1394-1400.
16. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guil-levin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohls-son S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG: Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367:214-223.
17. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoanti-bodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1:425-429. (Pubitemid 15173133)
18. Kallenberg CG: Pathogenesis of ANCA-asso-ciated vasculitis, an update. Clin Rev Allergy Immunol 2011; 41:224-231.
19. Gou SJ, Yuan J, Chen M, Yu F, Zhao MH: Circulating complement activation in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2013; 83:129-137.
20. Noris M, Mescia F, Remuzzi G: STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012; 8:622-633.
21. Chen M, Daha MR, Kallenberg CG: The complement system in systemic autoimmune disease. J Autoimmun 2010; 34:J276-J286.
22. Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis, a new look at an old entity. N Engl J Med 2012; 366:1119-1131.
23. D'Agati VD, Bomback AS: C3 glomerulopa-thy: what's in a name? Kidney Int 2012; 82: 379-381.
24. Zuber J, Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V; French Study Group for aHUS/C3G: Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 2012; 8: 643-657.
25. Weening JJ, D'Agati VD, Schwartz MM, Ses-han SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65:521-530.
26. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM: Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 2010; 21:1628-1636.
27. Working Group of the International IgA Ne-phropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Flo-rquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Sche-na FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H: The Oxford classification of IgA nephropathy: pathology definitions, correlations and classification. Kidney Int 2009; 76:546-556.
28. Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshi-ma A, Kaneko Y, Hiromura K, Ueki K, No-jima Y: Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glom-eruli affected by chronic lesions. Rheumatology 2008; 47:702-707. (Pubitemid 351619216)